ArticleBreast cancer research : BCR2026
Development and validation of an immune-related molecular subtyping model based on a four-gene prognostic biomarker signature and multi-omics integrative analysis in Luminal B breast cancer.
Junqi Long et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.